Home/ Stocks/ RCKT

Rocket Pharmaceuticals, Inc. Common Stock

RCKT XNAS

$2.38 -0.05 (-1.89%) ▼ 15-min delayed

Open

$2.41

High

$2.51

Low

$2.36

Volume

1.43M

Market Cap

$261.81M

About Rocket Pharmaceuticals, Inc. Common Stock

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 202 Website →

Related Market News

No specific coverage for RCKT yet. Check out our latest market news or earnings calendar.

Get RCKT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Rocket Pharmaceuticals, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.